These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
78 related articles for article (PubMed ID: 27523475)
1. Human flavin-containing monooxygenase 3: Structural mapping of gene polymorphisms and insights into molecular basis of drug binding. Gao C; Catucci G; Di Nardo G; Gilardi G; Sadeghi SJ Gene; 2016 Nov; 593(1):91-99. PubMed ID: 27523475 [TBL] [Abstract][Full Text] [Related]
2. Binding of methimazole and NADP(H) to human FMO3: In vitro and in silico studies. Gao C; Catucci G; Gilardi G; Sadeghi SJ Int J Biol Macromol; 2018 Oct; 118(Pt A):460-468. PubMed ID: 29959003 [TBL] [Abstract][Full Text] [Related]
3. In vitro drug metabolism by C-terminally truncated human flavin-containing monooxygenase 3. Catucci G; Gilardi G; Jeuken L; Sadeghi SJ Biochem Pharmacol; 2012 Feb; 83(4):551-8. PubMed ID: 22177984 [TBL] [Abstract][Full Text] [Related]
4. Potential for drug interactions mediated by polymorphic flavin-containing monooxygenase 3 in human livers. Shimizu M; Shiraishi A; Sato A; Nagashima S; Yamazaki H Drug Metab Pharmacokinet; 2015 Feb; 30(1):70-4. PubMed ID: 25760532 [TBL] [Abstract][Full Text] [Related]
5. Identification of human flavin-containing monooxygenase 3 substrates by a colorimetric screening assay. Catucci G; Polignano I; Cusumano D; Medana C; Gilardi G; Sadeghi SJ Anal Biochem; 2017 Apr; 522():46-52. PubMed ID: 28137602 [TBL] [Abstract][Full Text] [Related]
6. Entrapment of human flavin-containing monooxygenase 3 in the presence of gold nanoparticles: TEM, FTIR and electrocatalysis. Castrignanò S; Sadeghi SJ; Gilardi G Biochim Biophys Acta; 2012 Dec; 1820(12):2072-8. PubMed ID: 23036595 [TBL] [Abstract][Full Text] [Related]
7. Inactivation mechanism of N61S mutant of human FMO3 towards trimethylamine. Gao C; Catucci G; Castrignanò S; Gilardi G; Sadeghi SJ Sci Rep; 2017 Nov; 7(1):14668. PubMed ID: 29116146 [TBL] [Abstract][Full Text] [Related]
8. Direct electrochemistry of drug metabolizing human flavin-containing monooxygenase: electrochemical turnover of benzydamine and tamoxifen. Sadeghi SJ; Meirinhos R; Catucci G; Dodhia VR; Di Nardo G; Gilardi G J Am Chem Soc; 2010 Jan; 132(2):458-9. PubMed ID: 20028087 [TBL] [Abstract][Full Text] [Related]
9. Expression and characterization of functional dog flavin-containing monooxygenase 3. Lickteig AJ; Riley R; Melton RJ; Reitz BA; Fischer HD; Stevens JC Drug Metab Dispos; 2009 Oct; 37(10):1987-90. PubMed ID: 19635782 [TBL] [Abstract][Full Text] [Related]
10. Ligand stabilization and effect on unfolding by polymorphism in human flavin-containing monooxygenase 3. Catucci G; Aramini D; Sadeghi SJ; Gilardi G Int J Biol Macromol; 2020 Nov; 162():1484-1493. PubMed ID: 32781122 [TBL] [Abstract][Full Text] [Related]
13. Electro-catalysis by immobilised human flavin-containing monooxygenase isoform 3 (hFMO3). Castrignanò S; Sadeghi SJ; Gilardi G Anal Bioanal Chem; 2010 Oct; 398(3):1403-9. PubMed ID: 20652542 [TBL] [Abstract][Full Text] [Related]
14. N- and S-oxygenation activity of truncated human flavin-containing monooxygenase 3 and its common polymorphic variants. Bortolussi S; Catucci G; Gilardi G; Sadeghi SJ Arch Biochem Biophys; 2021 Jan; 697():108663. PubMed ID: 33152328 [TBL] [Abstract][Full Text] [Related]
15. Effect of genetic variants of the human flavin-containing monooxygenase 3 on N- and S-oxygenation activities. Shimizu M; Yano H; Nagashima S; Murayama N; Zhang J; Cashman JR; Yamazaki H Drug Metab Dispos; 2007 Mar; 35(3):328-30. PubMed ID: 17142560 [TBL] [Abstract][Full Text] [Related]
16. Effect of human flavin-containing monooxygenase 3 polymorphism on the metabolism of aurora kinase inhibitors. Catucci G; Occhipinti A; Maffei M; Gilardi G; Sadeghi SJ Int J Mol Sci; 2013 Jan; 14(2):2707-16. PubMed ID: 23358255 [TBL] [Abstract][Full Text] [Related]
17. Trimethylaminuria (fish odor syndrome): genotype characterization among Portuguese patients. Ferreira F; Esteves S; Almeida LS; Gaspar A; da Costa CD; Janeiro P; Bandeira A; Martins E; Teles EL; Garcia P; Azevedo L; Vilarinho L Gene; 2013 Sep; 527(1):366-70. PubMed ID: 23791655 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of immobilized hFMO3 on magnetic nanoparticles by capillary zone electrophoresis. Ramana P; Herman W; Hiroux C; Adams E; Augustijns P; Van Schepdael A Bioanalysis; 2017 Feb; 9(3):289-296. PubMed ID: 28084789 [TBL] [Abstract][Full Text] [Related]
19. Human flavin-containing monooxygenase 3 on graphene oxide for drug metabolism screening. Castrignanò S; Gilardi G; Sadeghi SJ Anal Chem; 2015 Mar; 87(5):2974-80. PubMed ID: 25630629 [TBL] [Abstract][Full Text] [Related]
20. Population-specific polymorphisms of the human FMO3 gene: significance for detoxication. Cashman JR; Akerman BR; Forrest SM; Treacy EP Drug Metab Dispos; 2000 Feb; 28(2):169-73. PubMed ID: 10640514 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]